NO20050801L - Prodrug av protonpumpe inhibitorer - Google Patents

Prodrug av protonpumpe inhibitorer

Info

Publication number
NO20050801L
NO20050801L NO20050801A NO20050801A NO20050801L NO 20050801 L NO20050801 L NO 20050801L NO 20050801 A NO20050801 A NO 20050801A NO 20050801 A NO20050801 A NO 20050801A NO 20050801 L NO20050801 L NO 20050801L
Authority
NO
Norway
Prior art keywords
proton pump
pump inhibitors
prodrug
prodrugs
bioavailability
Prior art date
Application number
NO20050801A
Other languages
English (en)
Norwegian (no)
Inventor
George Sachs
Jai Moo Shin
Michael E Garst
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of NO20050801L publication Critical patent/NO20050801L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/04Drugs for disorders of the respiratory system for throat disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
NO20050801A 2002-07-19 2005-02-15 Prodrug av protonpumpe inhibitorer NO20050801L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39745902P 2002-07-19 2002-07-19
PCT/US2003/022419 WO2004009583A2 (en) 2002-07-19 2003-07-15 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor

Publications (1)

Publication Number Publication Date
NO20050801L true NO20050801L (no) 2005-02-15

Family

ID=30771064

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050801A NO20050801L (no) 2002-07-19 2005-02-15 Prodrug av protonpumpe inhibitorer

Country Status (23)

Country Link
US (3) US6897227B2 (ko)
EP (1) EP1556371B1 (ko)
JP (1) JP4463103B2 (ko)
KR (2) KR100788778B1 (ko)
AT (1) ATE323695T1 (ko)
AU (1) AU2003259154B2 (ko)
BR (1) BR0312802A (ko)
CA (1) CA2492718C (ko)
CO (1) CO5690576A2 (ko)
DE (1) DE60304726T2 (ko)
DK (1) DK1556371T3 (ko)
ES (1) ES2263028T3 (ko)
HK (1) HK1079207A1 (ko)
IL (1) IL166371A0 (ko)
MX (1) MXPA05000657A (ko)
NO (1) NO20050801L (ko)
NZ (1) NZ538221A (ko)
PL (1) PL375255A1 (ko)
PT (1) PT1556371E (ko)
RU (1) RU2292342C2 (ko)
TW (1) TW200502231A (ko)
WO (1) WO2004009583A2 (ko)
ZA (1) ZA200501116B (ko)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
EP1534278A4 (en) * 2002-08-01 2006-09-06 Nitromed Inc NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD
PL379542A1 (pl) * 2003-07-15 2006-10-02 Allergan, Inc. Sposób wytwarzania izomerycznie czystych proleków inhibitorów pompy protonowej
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
WO2005039640A1 (en) * 2003-10-03 2005-05-06 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
EP1715861A2 (en) * 2004-02-18 2006-11-02 Allergan, Inc. Compositions comprising prodrugs of proton pump inhibitors
AU2005216863A1 (en) * 2004-02-18 2005-09-09 Allergan, Inc. Methods and compositions for the intravenous administration of compounds related to proton pump inhibitors
WO2005089758A1 (en) * 2004-03-11 2005-09-29 Allergan, Inc. Methods and compositions for the treatment of conditions related to gastric acid secretion
ES2327926T3 (es) 2004-04-28 2009-11-05 Hetero Drugs Limited Procedimiento de preparacion de compuestos de piridinilmetil-1h-benzimidazol en forma de enantiomeros simples o enantiomericamente enriquecidos.
WO2007073301A1 (en) * 2005-12-23 2007-06-28 Astrazeneca Ab Benzoimidazole derivatives as prodrugs of proton pump inhibitors
US20070265311A1 (en) * 2006-01-10 2007-11-15 Rubino Mark P Therapeutic Salt Compositions and Methods
CA2649946A1 (en) * 2006-05-09 2007-11-15 Astrazeneca Ab New sterilized parenteral formulation
US20070293543A1 (en) * 2006-06-19 2007-12-20 Edward Lee THRESHOLD BLOOD OMEPRAZOLE CONCENTRATION IS 50 NG/ML FOR THE MAINTENANCE OF INTRAGASTRIC pH OF AT LEAST 4.0 AFTER ORAL DOSING WITH CMA-OMEPRAZOLE, AGN 201904-Z
US20100317689A1 (en) * 2006-09-19 2010-12-16 Garst Michael E Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
US20100113524A1 (en) * 2006-09-19 2010-05-06 Garst Michael E Prodrugs of proton pump inhibitors including the (1h-pyrrol-1-yl)-1h-benzimidazole moiety
US20100265240A1 (en) * 2007-10-05 2010-10-21 Lg Electronics Inc. Plasma display device
KR20090035195A (ko) * 2007-10-05 2009-04-09 엘지전자 주식회사 플라즈마 디스플레이 장치
KR100895333B1 (ko) * 2007-11-01 2009-05-07 엘지전자 주식회사 플라즈마 디스플레이 패널의 구동 방법 및 그를 이용한플라즈마 디스플레이 장치
US8927559B2 (en) 2010-10-11 2015-01-06 Merck Sharp & Dohme Corp. Quinazolinone-type compounds as CRTH2 antagonists
CA2818597A1 (en) 2010-12-23 2012-06-28 Merck Sharp & Dohme Corp. Quinoxalines and aza-quinoxalines as crth2 receptor modulators
EP2661265B1 (en) 2010-12-23 2017-03-08 Merck Sharp & Dohme Corp. Quinolines and aza-quinolines as crth2 receptor modulators
CA2973370A1 (en) * 2015-01-09 2016-07-14 The Regents Of The University Of California Compositions and methods for treating gastrointestinal infections
CN108997177A (zh) * 2018-09-04 2018-12-14 邵阳学院 一种微波促进n-苯磺酰基硝基苯胺类化合物合成的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US430042A (en) * 1890-06-10 Valve
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
IL76839A (en) 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8505112D0 (sv) 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
US4758597A (en) 1987-05-15 1988-07-19 University Patents, Inc. Carenadiol and derivatives
US4965269A (en) 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5045522A (en) 1990-03-27 1991-09-03 Phillips Petroleum Company Absorption composition comprising zinc titanate for removal of hydrogen sulfide from fluid streams
EP0593463B1 (en) 1990-06-20 1999-09-15 Astra Aktiebolag Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
EE03312B1 (et) * 1994-06-10 2000-12-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Asendatud arüülalküültioalküültiopüridiinid Helicobacter bakterite tõrjeks, nende valmistamismeetod ja kasutamine ravimite valmistamiseks
US5708017A (en) 1995-04-04 1998-01-13 Merck & Co., Inc. Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors
JP4346243B2 (ja) * 1998-08-10 2009-10-21 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア プロトン・ポンプ・インヒビターのプロドラッグ
US6093734A (en) 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
DE69921829T2 (de) * 1998-08-12 2005-10-27 Gilead Sciences, Inc., Foster City Verfahren zur herstellung von 1,3-oxathiolannukleoside
SE0002476D0 (sv) 2000-06-30 2000-06-30 Astrazeneca Ab New compounds
US6599167B2 (en) 2000-09-27 2003-07-29 Glenn Waltz Game call holder and amplifying device
CA2425363A1 (en) * 2000-10-12 2003-04-10 Fumihiko Sato Benzimidazole compounds, process for producing the same and use thereof

Also Published As

Publication number Publication date
HK1079207A1 (en) 2006-03-31
IL166371A0 (en) 2006-01-16
TW200502231A (en) 2005-01-16
ZA200501116B (en) 2006-11-29
KR20070005029A (ko) 2007-01-09
KR100822981B1 (ko) 2008-04-16
US6897227B2 (en) 2005-05-24
EP1556371B1 (en) 2006-04-19
CA2492718C (en) 2010-12-21
DE60304726D1 (de) 2006-05-24
WO2004009583A2 (en) 2004-01-29
ATE323695T1 (de) 2006-05-15
CA2492718A1 (en) 2004-01-29
KR20050047078A (ko) 2005-05-19
JP4463103B2 (ja) 2010-05-12
RU2005105564A (ru) 2005-10-10
RU2292342C2 (ru) 2007-01-27
KR100788778B1 (ko) 2007-12-27
DE60304726T2 (de) 2007-08-09
EP1556371A2 (en) 2005-07-27
ES2263028T3 (es) 2006-12-01
NZ538221A (en) 2006-11-30
AU2003259154B2 (en) 2006-12-07
US20040102484A1 (en) 2004-05-27
PT1556371E (pt) 2006-09-29
WO2004009583A3 (en) 2004-03-18
DK1556371T3 (da) 2006-08-21
AU2003259154C1 (en) 2004-02-09
JP2005536519A (ja) 2005-12-02
AU2003259154A1 (en) 2004-02-09
MXPA05000657A (es) 2005-08-19
BR0312802A (pt) 2005-04-19
PL375255A1 (en) 2005-11-28
US20050182101A1 (en) 2005-08-18
US20050143423A1 (en) 2005-06-30
CO5690576A2 (es) 2006-10-31

Similar Documents

Publication Publication Date Title
NO20050801L (no) Prodrug av protonpumpe inhibitorer
NO20071095L (no) Hittil ukjente tiofenderivater
NO20071617L (no) Indozolonderivater som 11B-HSD1-inhibitorer
NO20055135L (no) Fenylguinoliner og deres anvendelse som ostrogenreseptormodulatorer
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
NO20091395L (no) Nye tiofenderivater
NO20082793L (no) Nye tiofenderivater
NO20076648L (no) Novel thiophene derivatives
NO20063925L (no) Indazolderivater som inhibitorer av hormonsensitiv lipase
DE60210944D1 (de) N-substituierte heterocyclische nichtaryl-nmda/nr2b-antagonisten
NO20054848L (no) Substituerte p-diaminobenzenderivater
NO20064077L (no) Kemokinreseptorantagonister
NO20075298L (no) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
NO20091553L (no) Fenylderivater og deres anvendelse som immunmodulatorer
DK1784404T3 (da) Pyrrolo[2,3-c]pyridinderivater samt fremgangsmåder til deres fremstilling
NO20066055L (no) Pyridinderivater
NO20070557L (no) Ftalazinderivater som PARP-inhibitorer
NO20070445L (no) Pyrimidinderivater.
DK2263674T3 (da) 10,10-Dialkyl-prostansyrederivater som midler til sænkning af intraokulært tryk
NO20054135L (no) Kipolinon/benzoksazin derivater og anvendelser derav
NO20080554L (no) Pyrazolonderivater
NO20084543L (no) Benzimidazolderivater
ATE322487T1 (de) Hydroxamsäure-derivate
NO20071805L (no) Alkylidentetrahydronaftalenderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application